Zirl, Austria

Simon Schafferer

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biocrates Life Sciences Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Schafferer. Retrieved from https://idiyas.com/inventor/simon-schafferer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Schafferer: Innovator in Ovarian Cancer Assessment

Introduction

Simon Schafferer is a notable inventor based in Zirl, Austria. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of ovarian cancer. His work focuses on developing innovative solutions that enhance the sensitivity of cancer detection, especially in the early stages of the disease.

Latest Patents

Simon Schafferer holds a patent for a metabolic biomarker set designed for assessing ovarian cancer. This invention relates to new biomarkers that improve the sensitivity of ovarian cancer assessments. The patent also includes a method for evaluating ovarian cancer in patients and a kit for implementing this method.

Career Highlights

Simon is associated with Biocrates Life Sciences AG, a company that specializes in biomarker research and development. His role at Biocrates has allowed him to work on cutting-edge technologies that aim to improve cancer diagnostics. His dedication to innovation in this field has positioned him as a key figure in medical research.

Collaborations

Simon collaborates with esteemed colleagues, including Udo Müller and Barbara Burwinkel. Their combined expertise contributes to the advancement of research in cancer biomarkers and diagnostics.

Conclusion

Simon Schafferer is a pioneering inventor whose work in ovarian cancer assessment is making a significant impact in the medical field. His innovative approach to biomarker development is paving the way for more effective cancer detection methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…